about
Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseEpigenetic control of HIV-1 post integration latency: implications for therapyChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsThe intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages.Targeting the Brain Reservoirs: Toward an HIV CureBioinformatics and HIV latency.Sterile alpha motif and histidine/aspartic acid domain-containing protein 1 (SAMHD1)-facilitated HIV restriction in astrocytes is regulated by miRNA-181a.Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies.Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.Gold nanoparticles to improve HIV drug delivery.HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?HIV-specific CD8⁺ T cells and HIV eradicationTowards a scalable HIV cure research agenda: the role of co-infections.Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections.Proliferation of Perivascular Macrophages Contributes to the Development of Encephalitic Lesions in HIV-Infected Humans and in SIV-Infected Macaques.Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy.The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication.Interventions for Neurocognitive Dysfunction.Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities.T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses.Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.HIV Alters Gap Junction-Mediated Intercellular Communication in Human Brain Pericytes.In vitro modeling of HIV proviral activity in microglia.When do models of NeuroAIDS faithfully imitate "the real thing"?HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART.Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes.The role of catecholamines in HIV neuropathogenesis.Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation.Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice.HPA-axis genes as potential risk variants for neurocognitive decline in trauma-exposed, HIV-positive females
P2860
Q26770397-7008E498-7919-44C4-AC48-A7B6A2AF591EQ26781191-9B715739-ACED-418E-913A-8CC7DC52485AQ26781511-4D32D688-5507-41D1-BE6C-8A383D657E84Q27304947-D0AFDB94-C49F-4BA2-9BBF-F1890CB29D02Q28075694-ADA3E646-9609-4B92-92BB-BE9F92AE7012Q28081427-737A048D-95E0-4978-AF33-F5E01BCB1410Q34472532-E7A8C09F-1AB8-4C87-BC31-DC11C9B3D22FQ35582225-C011020B-D519-4E9A-8ABD-ED1A9B5055AAQ35606068-3B3E299B-413C-402C-9437-5293E2A1F116Q35847982-2F5BE1A4-2D5F-4CBE-89AF-60D1F5696F62Q36121883-9C7B606A-03F3-49BA-B747-2598A0A15312Q36515071-9BD57F5F-CE32-4ED4-A94E-C2C75E456F2CQ36540033-24F87D30-8537-418E-A33E-EBC3B38DCEFEQ37182704-4F7158F9-EA42-4491-B153-D9F02BE0D423Q37244320-68B08E01-8DD8-413E-8A0F-13B0A7CF355AQ37354047-D685F83C-2415-4D90-97DF-93225F9FAAF8Q38419425-10524693-D88B-4DBD-8349-E8E62F4F952CQ38767396-DB59A294-84C7-4D7A-8D59-5F8FF9ECB5BDQ38884364-9D459568-1522-4B56-92E9-9A13EFE7F098Q38924992-ABA41B7A-82E1-445B-BD59-70270B58AB05Q40256176-580FCDAE-4217-43F7-A2FA-5A18907F4A8FQ41933638-9E27CF94-1BE1-4DF2-B282-A69DCDDC85C0Q43564279-CD942B1D-CC1D-4D5A-AC08-894FC4CE8429Q46229748-BD81470F-D260-4CCC-9F67-0A92D236B733Q47241702-A663D2E5-FDA3-4420-B365-D316154BBF7CQ47427869-B75341BE-6C83-4CBC-9A49-904174E61812Q47563724-299DDB91-4631-42DF-9986-81DBA726C9E5Q49990061-7ABA1E93-3079-4726-B60E-79A9B7621C3AQ51336032-6926E9DE-1C2A-478C-9A34-404F60439640Q53828206-6D32D7D9-8B94-4063-BBE2-A8209E919D4EQ55315393-F46D1647-819F-4695-8655-76B3537EB12AQ55346907-8CAD20FA-C0DD-4B8F-A749-04DA06448F87Q57490403-ABEF8FC4-8723-4C55-B73E-F8EEBE8D075C
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Is the central nervous system a reservoir of HIV-1?
@ast
Is the central nervous system a reservoir of HIV-1?
@en
Is the central nervous system a reservoir of HIV-1?
@nl
type
label
Is the central nervous system a reservoir of HIV-1?
@ast
Is the central nervous system a reservoir of HIV-1?
@en
Is the central nervous system a reservoir of HIV-1?
@nl
prefLabel
Is the central nervous system a reservoir of HIV-1?
@ast
Is the central nervous system a reservoir of HIV-1?
@en
Is the central nervous system a reservoir of HIV-1?
@nl
P2093
P2860
P1476
Is the central nervous system a reservoir of HIV-1?
@en
P2093
Lachlan R Gray
Melissa J Churchill
Paul R Gorry
Steve L Wesselingh
P2860
P304
P356
10.1097/COH.0000000000000108
P577
2014-11-01T00:00:00Z